Recurrent Breast Cancer Completed Phase 1 / 2 Trials for Cefotaxime (DB00493)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

DBCOND0028640 (Recurrent Breast Cancer)Completed1 / 2 IdentifierTitlePurposeDrugs
NCT00331552Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast CancerTreatment